Coordination modes of multidentate ligands in fac-[Re(CO)(3)(polyaminocarboxylate)] analogues of (99m)Tc radiopharmaceuticals. dependence on aqueous solution reaction conditions.

We study Re analogues of (99m)Tc renal agents to interpret previous results at the (99m)Tc tracer level. The relative propensities of amine donors versus carboxylate oxygen donors of four L = polyaminocarboxylate ligands to coordinate in fac-[Re(I)(CO)(3)L](n) complexes were assessed by examining the reaction of fac-[Re(I)(CO)(3)(H(2)O)(3)](+) under conditions differing in acidity and temperature. All four L [N,N-bis-(2-aminoethyl)glycine (DTGH), N,N-ethylenediaminediacetic acid, diethylenetriamine-N-malonic acid, and diethylenetriamine-N-acetic acid] can coordinate as tridentate ligands while creating a dangling chain terminated in a carboxyl group. Dangling carboxyl groups facilitate renal clearance in fac-[(99m)Tc(I)(CO)(3)L](n) agents. Under neutral conditions, the four ligands each gave two fac-[Re(I)(CO)(3)L](n) products with HPLC traces correlating well with known traces of the fac-[(99m)Tc(I)(CO)(3)L](n) mixtures. Such mixtures are common in renal agents because the needed dangling carboxyl group can compete for a coordination site. However, the HPLC separations needed to assess the biodistribution of a single tracer are impractical in a clinical setting. One goal in investigating this Re chemistry is to identify conditions for avoiding this problem of mixtures in preparations of fac-[(99m)Tc(I)(CO)(3)L](n) renal tracers. After separation and isolation of the fac-[Re(I)(CO)(3)L](n) products, NMR analysis of all products and single crystal X-ray crystallographic analysis of both DTGH products, as well as one product each from the other L, allowed us to establish coordination mode unambiguously. The product favored in acidic conditions has a dangling amine chain and more bound oxygen. The product favored in basic conditions has a dangling carboxyl chain and more bound nitrogen. At the elevated temperatures used for simulating tracer preparation, equilibration was facile (ca. 1 h or less), allowing selective formation of one product by utilizing acidic or basic conditions. The results of this fundamental study offer protocols and guidance useful for the design and preparation of fac-[(99m)Tc(I)(CO)(3)L](n) agents consisting of a single tracer.

[1]  L. Marzilli,et al.  99mTc(CO)3(NTA): A 99mTc Renal Tracer with Pharmacokinetic Properties Comparable to Those of 131I-OIH in Healthy Volunteers , 2010, Journal of Nuclear Medicine.

[2]  L. Marzilli,et al.  99mTc(CO)3-Nitrilotriacetic Acid: A New Renal Radiopharmaceutical Showing Pharmacokinetic Properties in Rats Comparable to Those of 131I-OIH , 2009, Journal of Nuclear Medicine.

[3]  J. Valliant,et al.  Expedient multi-step synthesis of organometallic complexes of Tc and Re in high effective specific activity. A new platform for the production of molecular imaging and therapy agents. , 2008, Inorganic chemistry.

[4]  L. Marzilli,et al.  fac-[Re(CO)(3)L](+) complexes with N-CH(2)-CH(2)-X-CH(2)-CH(2)-N tridentate ligands. synthetic, X-ray crystallographic, and NMR spectroscopic investigations. , 2007, Inorganic chemistry.

[5]  Kristie M. Adams,et al.  Reactions of fac-[Re(CO)3(H2O)3]+ with nucleoside diphosphates and thiamine diphosphate in aqueous solution investigated by multinuclear NMR spectroscopy. , 2007, Inorganic chemistry.

[6]  L. Marzilli,et al.  Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues. , 2007, Nuclear medicine and biology.

[7]  Kristie M. Adams,et al.  fac-[Re(CO)3(H2O)3]+ nucleoside monophosphate adducts investigated in aqueous solution by multinuclear NMR spectroscopy. , 2007, Inorganic chemistry.

[8]  L. Marzilli,et al.  Rhenium analogues of promising renal imaging agents with a [99mTc(CO)3]+ core bound to cysteine-derived dipeptides, including lanthionine. , 2007, Inorganic chemistry.

[9]  J. Correia,et al.  In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys). , 2007, Bioconjugate chemistry.

[10]  Yu Liu,et al.  Amino acids labeled with [99mTc(CO)3]+ and recognized by the L-type amino acid transporter LAT1. , 2006, Journal of the American Chemical Society.

[11]  T. Nayak,et al.  Linkage Effects on Binding Affinity and Activation of GPR30 and Estrogen Receptors ERα/β with Tridentate Pyridin-2-yl Hydrazine Tricarbonyl−Re/99mTc(I) Chelates , 2006 .

[12]  L. Marzilli,et al.  First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  J. Zubieta,et al.  Thiol- and thioether-based bifunctional chelates for the {M(CO)3}+ core (M = Tc, Re). , 2005, Inorganic chemistry.

[14]  B. Spingler,et al.  Picolylamine-methylphosphonic acid esters as tridentate ligands for the labeling of alcohols with the fac-[M(CO)3]+ core (M = 99mTc, Re): synthesis and biodistribution of model compounds and of a 99mTc-labeled cobinamide. , 2005, Nuclear medicine and biology.

[15]  L. Marzilli,et al.  Re(CO)(3) complexes synthesized via an improved preparation of aqueous fac-[Re(CO)(3)(H(2)O)(3)](+) as an aid in assessing (99m)Tc imaging agents. Structural characterization and solution behavior of complexes with thioether-bearing amino acids as tridentate ligands. , 2005, Inorganic chemistry.

[16]  L. Marzilli,et al.  Complexes having the fac-[M(CO)3]+ core (M=Tc, Re) useful in radiopharmaceuticals: X-ray and NMR structural characterization and density functional calculations of species containing two sp3 N donors and one sp3 O donor. , 2004, Inorganic chemistry.

[17]  M. Saurer,et al.  99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin. , 2004, Bioconjugate chemistry.

[18]  L. Hansen,et al.  99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  Alun G. Jones,et al.  N-(2-Mercaptoethyl)picolylamine as a diaminomonothiolate ligand for the "fac-[Re(CO)3]+" core. , 2002, Inorganic chemistry.

[20]  M. Lázníček,et al.  Analysis of renal handling of radiopharmaceuticals. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[21]  R. Schibli,et al.  Current use and future potential of organometallic radiopharmaceuticals , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  L. Hansen,et al.  New N(3)S donor ligand small peptide analogues of the N-mercaptoacetyl-glycylglycylglycine ligand in the clinically used Tc-99m renal imaging agent: evidence for unusual amide oxygen coordination by two new ligands. , 2002, Inorganic chemistry.

[23]  R. Schibli,et al.  Development of novel water-soluble, organometallic compounds for potential use in nuclear medicine: synthesis, characterization, and (1)H and (31)P NMR investigations of the complexes fac-[ReBr(CO)3L] (L=bis(bis(hydroxymethyl)phosphino)ethane, bis(bis(hydroxymethyl)phosphino)benzene). , 2001, Inorganic chemistry.

[24]  R. Schibli,et al.  Synthesis and properties of boranocarbonate: a convenient in situ CO source for the aqueous preparation of [(99m)Tc(OH(2))3(CO)3]+. , 2001, Journal of the American Chemical Society.

[25]  L. Hansen,et al.  Nature of cysteine-based Re(V)=O(N2S2) radiopharmaceuticals at physiological pH ascertained by investigation of a new complex with a meso N2S2 ligand having carboxyl groups anti to the oxo group. , 2000, Inorganic chemistry.

[26]  R. Schibli,et al.  Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. , 2000, Bioconjugate chemistry.

[27]  H. Spies,et al.  Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules. , 2000, Bioconjugate chemistry.

[28]  R. Schibli,et al.  Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Andreas Plückthun,et al.  Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)–carbonyl complex , 1999, Nature Biotechnology.

[30]  L. Hansen,et al.  Re(V)=O(N(2)S(2)) Complexes with N(2)S(2) = Thio-Amido-Secondary Amine-Thio Chelate Ligands: Synthesis, Structure, and Characterization of Solution Forms. , 1999, Inorganic chemistry.

[31]  R. Banerjee,et al.  Oxorhenium(V) and Oxotechnetium(V) Complexes of Cysteine. , 1998, Inorganic chemistry.

[32]  H. Vanbilloen,et al.  Characteristics and biological behaviour of 99mTc-labelled hydroxyacetyltriglycine, a potential alternative to 99mTc-MAG3 , 1997, European Journal of Nuclear Medicine.

[33]  M. Marmion,et al.  Preparation, characterization, and biological evaluation of technetium(V) and rhenium(V) complexes of novel heterocyclic tetradentate N3S ligands. , 1997, Bioconjugate chemistry.

[34]  L. Hansen,et al.  Comparison of technetium-99m-ll-EC isomers in rats and humans. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  F. Fazio,et al.  99mTc-2GAM: a tracer for renal imaging. , 1996, Nuclear medicine and biology.

[36]  L. Hansen,et al.  Evaluation of technetium-99m-triamide-mercaptide complexes designed to identify properties favoring renal tubular transport. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  D. Eshima,et al.  Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent. , 1992, Seminars in nuclear medicine.

[38]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[39]  Y. Kanai,et al.  Transport of 99mTc-MAG3 via rat renal organic anion transporter 1. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  R. Alberto,et al.  Preparation of no-carrier-added technetium-99m complexes via metal-assisted cleavage from a solid phase. , 2004, Bioconjugate chemistry.

[41]  J. Zubieta,et al.  A new strategy for the preparation of peptide-targeted radiopharmaceuticals based on an fmoc-lysine-derived single amino acid chelate (SAAC). automated solid-phase synthesis, NMR characterization, and in vitro screening of fMLF(SAAC)G and fMLF[(SAAC-Re(CO)3)+]G. , 2004, Bioconjugate chemistry.

[42]  R. Alberto,et al.  Mono‐, bi‐, or tridentate ligands? The labeling of peptides with 99mTc‐carbonyls , 2004, Biopolymers.

[43]  G. Bormans,et al.  Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteers , 2004, European Journal of Nuclear Medicine.